Skin Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Skin Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
$ 2500
|
|
|
Pancreatic Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Pancreatic Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic dev
|
$ 2500
|
|
|
Pain – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Pain - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pain, complet
|
$ 2500
|
|
|
Gynecological Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Gynecological Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeut
|
$ 2500
|
|
|
Heart Transplantation – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Heart Transplantation - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therape
|
$ 2000
|
|
|
Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. Thi
|
$ 2000
|
|
|
Hypoxic-Ischemic Encephalopathy – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Hypoxic-Ischemic Encephalopathy - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides inform
|
$ 2000
|
|
|
Infectitious Diarrhea – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Infectitious Diarrhea - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therape
|
$ 2000
|
|
|
Portal Hypertension – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Portal Hypertension - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic
|
$ 2000
|
|
|
Premenstrual Syndrome – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Premenstrual Syndrome - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therape
|
$ 2000
|
|
|
Raynauds Disease – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Raynauds Disease - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic devel
|
$ 2000
|
|
|
Shigella Infections (Shigellosis) – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Shigella Infections (Shigellosis) - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides in
|
$ 2000
|
|
|
Spinal Stenosis – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Spinal Stenosis - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic develop
|
$ 2000
|
|
|
Neuralgia – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Neuralgia - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Neu
|
$ 2000
|
|
|
Vaginitis – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Vaginitis - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vag
|
$ 2000
|
|
|
Gastric Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Gastric Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic developme
|
$ 2000
|
|
|
Colorectal Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Colorectal Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic dev
|
$ 2000
|
|
|
Hepatocellular Carcinoma – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Hepatocellular Carcinoma - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the t
|
$ 2000
|
|
|
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2
|
$ 2000
|
|
|
Hepatitis B – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Hepatitis B - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
$ 2000
|
|
|